Cargando…

New drug developments in metastatic gastric cancer

Metastatic gastric cancer is associated with a poor prognosis and novel treatment options are desperately needed. The development of targeted therapies heralded a new era for the management of metastatic gastric cancer, however results from clinical trials of numerous targeted agents have been mixed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Aaron C., Chan, David L., Faisal, Wasek, Pavlakis, Nick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236851/ https://www.ncbi.nlm.nih.gov/pubmed/30455742 http://dx.doi.org/10.1177/1756284818808072

Ejemplares similares

Anti-Angiogenic Therapy in ALK Rearranged Non-Small Cell Lung Cancer (NSCLC)
por: Tan, Aaron C., et al.
Publicado: (2022)

New developments in the treatment of metastatic gastric cancer: focus on trastuzumab
por: Rose, Jeffrey S, et al.
Publicado: (2011)

The effect of anti-angiogenic agents on overall survival in metastatic oesophago-gastric cancer: A systematic review and meta-analysis
por: Chan, David L., et al.
Publicado: (2017)

Vitamin E in Cancer Treatment: A Review of Clinical Applications in Randomized Control Trials
por: Donnelly, Jennifer, et al.
Publicado: (2022)

Drug Development Against Metastatic Cancers
por: Wang, Chen, et al.
Publicado: (2017)

Does the Chemotherapy Backbone Impact on the Efficacy of Targeted Agents in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis of the Literature
por: Chan, David L., et al.
Publicado: (2015)

Correction: Does the Chemotherapy Backbone Impact on the Efficacy of Targeted Agents in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis of the Literature
por: Chan, David L., et al.
Publicado: (2015)

The role of biological therapy in metastatic colorectal cancer after first-line treatment: a meta-analysis of randomised trials
por: Segelov, E, et al.
Publicado: (2014)

Enduring complete metabolic response in metastatic adenocarcinoma of the gastro-oesophageal junction
por: Li, Minmin, et al.
Publicado: (2014)

Role of Ketamine and Methadone as Adjunctive Therapy in Complex Pain Management: A Case Report and Literature Review
por: Faisal, Wasek, et al.
Publicado: (2017)

European-Australasian consensus on the management of advanced gastric and gastro-oesophageal junction cancer: current practice and new directions
por: Pavlakis, Nick, et al.
Publicado: (2022)

New drugs for the treatment of metastatic colorectal cancer
por: Cherri, Sara, et al.
Publicado: (2021)

Osteoclast inhibitors to prevent bone metastases in men with high-risk, non-metastatic prostate cancer: A systematic review and meta-analysis
por: Hayes, Aimee R., et al.
Publicado: (2018)

Oral fluoropyrimidines among the new drugs for patients with metastatic breast cancer
por: Leonard, R C F
Publicado: (2001)

Systematic Review and Meta-Analysis on the Role of Chemotherapy in Advanced and Metastatic Neuroendocrine Tumor (NET)
por: Wong, Matthew H., et al.
Publicado: (2016)

Neoadjuvant immunotherapy for non-small cell lung cancer: right drugs, right patient, right time?
por: Ahern, Elizabeth, et al.
Publicado: (2021)

New developments in targeted therapy for metastatic colorectal cancer
por: Wong, Ambrose H. N., et al.
Publicado: (2023)

Metastatic gastric cancer – focus on targeted therapies
por: Meza-Junco, Judith, et al.
Publicado: (2012)

Treatment and Prevention of Bone Metastases from Breast Cancer: A Comprehensive Review of Evidence for Clinical Practice
por: Li, Bob T., et al.
Publicado: (2014)

Late-line treatment in metastatic gastric cancer: today and tomorrow
por: Smyth, Elizabeth C., et al.
Publicado: (2019)

Autophagy: A Key Player in Pancreatic Cancer Progression and a Potential Drug Target
por: Gillson, Josef, et al.
Publicado: (2022)

Third-line systemic treatment in advanced/metastatic gastric cancer: a comprehensive review
por: Chan, Wing-lok, et al.
Publicado: (2019)

Repurposed Drugs in Gastric Cancer
por: Araújo, Diana, et al.
Publicado: (2022)

Not All Body Surface Area Formulas Are the Same, but Does It Matter?
por: Faisal, Wasek, et al.
Publicado: (2016)

Anti-PD-1 Monoclonal Antibodies (mAbs) Are Superior to Anti-PD-L1 mAbs When Combined with Chemotherapy in First-Line Treatment for Metastatic Non-Small Cell Lung Cancer (mNSCLC): A Network Meta-Analysis
por: Wei, Joe Q., et al.
Publicado: (2023)

Metastatic Gastric Cancer to the Colon
por: Then, Eric Omar, et al.
Publicado: (2021)

Resistance to targeted therapy in metastatic colorectal cancer: Current status and new developments
por: Tang, Yuan-Ling, et al.
Publicado: (2023)

Molecularly targeted drugs for metastatic colorectal cancer
por: Cheng, Ying-dong, et al.
Publicado: (2013)

Oral drugs in the treatment of metastatic colorectal cancer
por: García-Alfonso, Pilar, et al.
Publicado: (2021)

Multimodality Treatment in Metastatic Gastric Cancer: From Past to Next Future
por: Parisi, Alessandro, et al.
Publicado: (2020)

Molecular alterations of cancer cell and tumour microenvironment in metastatic gastric cancer
por: Li, Weilin, et al.
Publicado: (2018)

A new era of cancer treatment: carbon nanotubes as drug delivery tools
por: Madani, Seyed Yazdan, et al.
Publicado: (2011)

Rearranged During Transfection Fusions in Non-Small Cell Lung Cancer
por: O’Leary, Connor, et al.
Publicado: (2019)

The roles of extracellular vesicles in gastric cancer development, microenvironment, anti-cancer drug resistance, and therapy
por: Huang, Tingting, et al.
Publicado: (2019)

New therapies for advanced, recurrent, and metastatic endometrial cancers
por: Makker, Vicky, et al.
Publicado: (2017)

Gastrin and Gastric Cancer
por: Smith, Jill P., et al.
Publicado: (2017)

The effectivity of targeted therapy and immunotherapy in patients with advanced metastatic and non-metastatic cancer of the esophagus and esophago-gastric junction
por: Valkema, M. J., et al.
Publicado: (2022)

The quantum leap in therapeutics for advanced ALK+ non-small cell lung cancer and pursuit to cure with precision medicine
por: Itchins, Malinda, et al.
Publicado: (2022)

Insight into the molecular mechanisms of gastric cancer stem cell in drug resistance of gastric cancer
por: Xiong, Jixian, et al.
Publicado: (2022)

Gastric Cancer with Radiographically Occult Metastatic Disease: Biology, Challenges, and Diagnostic Approaches
por: Sanjeevaiah, Aravind, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_38bcc3f5tt431e5884v3nf4kub